Search

Author/Creator Klassen, Preston

1. Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trial. Issue 4 (10th October 2019)

Authors:
Torres, Fernando; Farber, Harrison; Ristic, Arsen; McLaughlin, Vallerie; Adams, John; Zhang, Jinkun; Klassen, Preston; Shanahan, William; Grundy, John; Hoffmann, Ines; Cabell, Christopher; Escribano Subías, Pilar; Sood, Namita; Keogh, Anne; D'Souza, Gwyn; Rubin, Lewis
Journal:
European respiratory journal
Issue:
Volume 54:Issue 4(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. FO020A PHASE 2 OPEN-LABEL SINGLE-ARM STUDY TO ASSESS THE EFFECT OF SNF472 ON WOUND HEALING IN CALCIPHYLAXIS (CALCIFIC UREMIC ARTERIOLOPATHY) PATIENTS. (18th May 2018)

Authors:
Brandenburg, Vincent; Sinha, Smeeta; Torregrosa, Jose-Vicente; Berman, Lance; Miller, Stephan; Canals, Ana-Zeralda; Bahr, Daun; Klassen, Preston; Joubert, Pieter; Salcedo, Carolina; Garg, Rekha; Perelló, Joan
Journal:
Nephrology dialysis transplantation
Issue:
Volume 33(2018)Supplement 1
Page Start:
i9
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study. (21st January 2021)

Authors:
Vermeire, Séverine; Chiorean, Michael; Panés, Julián; Peyrin-Biroulet, Laurent; Zhang, Jinkun; Sands, Bruce E; Lazin, Krisztina; Klassen, Preston; Naik, Snehal U; Cabell, Christopher H; Sandborn, William J
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15:Number 6(2021)
Page Start:
950
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Long‐Term Efficacy and Safety of Etrasimod for Ulcerative Colitis: Results From the Open‐Label Extension of the OASIS Study: 764. (October 2019)

Authors:
Chiorean, Michael; Vermeire, Séverine; Panés, Julian; Peyrin‐Biroulet, Laurent; Zhang, Jinkun; Sands, Bruce E.; Lazin, Krisztina; Cabell, Chris H.; Naik, Snehal U.; Klassen, Preston; Sandborn, William J.
Journal:
American journal of gastroenterology
Issue:
Volume 114 (2019)ACG Abstracts 1:Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety, Pharmacokinetics, and Efficacy of Olorinab, a Peripherally Acting, Highly Selective, Full Agonist of the Cannabinoid Receptor 2, in a Phase 2a Study of Patients With Chronic Abdominal Pain Associated With Crohn's Disease. Issue 1 (24th October 2020)

Authors:
Yacyshyn, Bruce R; Hanauer, Stephen; Klassen, Preston; English, Brett A; Stauber, Kathe; Barish, Charles F; Gilder, Kye; Turner, Stewart; Higgins, Peter D R
Journal:
Crohn's & colitis 360
Issue:
Volume 3:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗